Epimune Partners With Leading Clinical and Research Centers

Industry Partners

Research Funding

EPI-LYMPH

KMU-innovativ-23: EPI-LYMPH - Development of an epigenetic test to support diagnosis, prognosis and

monitoring of malignant B-cell Non-Hodgkin Lymphoma (NHL); TP A
Supported by the German Federal Ministry of Education and Research

i.Mune

Research project aiming at developing a miniaturized device to perform epigenetic immune cell quantification in patient-side settings. Supported by Investitionsbank Berlin (IBB) and European Regional Development Fund (ERDF). Co-operation partner Fraunhofer IZI-BB (Potsdam-Golm, Germany). 

Download
i.Mune - Poster
iMune_Poster.pdf
Adobe Acrobat Document 880.1 KB

 

e:KID

e:Kid is a collaborative project involving clinical departments, research institutes, biometrics departments, translational, and industrial partners. The aim of e:Kid is creating and validating a systems medicine based model allowing personalized therapy at early stage after kidney transplantation. Epimune's activities aim at the discovery and development of epigenetic biomarkers for risk assessment, prognosis, and prediction of post transplant course upon kidney transplantation. Supported by the German Federal Ministry of Education and Research (BMBF)

 

Software Development

Development of a web-based data analysis tool. Supported by Investitionsbank Berlin (IBB). Co-operation partner Technical University (TH) Wildau